CM-101 in PSC Patients -The SPRING Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2025

Conditions
Primary Sclerosing Cholangitis
Interventions
BIOLOGICAL

Anti-human CCL24 monoclonal antibody (CM-101)

Anti-human CCL24 monoclonal antibody (CM-101) 100 mg Intravenous Infusion over 60 minutes (±5 minutes)

OTHER

Placebo

Placebo - intravenous infusion

Trial Locations (33)

8036

Hospital Clínic de Barcelona - site P67, Barcelona

20246

Universitätsklinikum Hamburg-Eppendorf (UKE) - site P47, Hamburg

23284

Virginia Commonwealth - site P94, Richmond

28034

Hospital Universitario Ramón y Cajal - site P61, Madrid

46026

Hospital Universitari i Politècnic La Fe - site P64, Valencia

50009

Hospital Universitario Miguel Servet - site P65, Zaragoza

60611

Northwestern University - site P77, Chicago

75203

Methodist Dallas Medical Center - site P72, Dallas

91120

Hadassah Ein Kereme - site P21, Jerusalem

92037

Scripps Clinic Torrey Pines - site P83, La Jolla

95816-5202

UC Davis Health System - Midtown Ambulatory Care Center - site P79, Sacramento

02114

Massachusetts General Hospital - site P95, Boston

02215

Harvard Medical School - Beth Israel Deaconess Medical Center (BIDMC) - Liver Center - site P81, Boston

38138-1741

Gastro One - GI Diagnostic and Therapeutic Endoscopy Center - 1310 Wolf Park - site P82, Germantown

Unknown

Klinikum der Johann Wolfgang Goethe-Universitaet - site P42, Frankfurt am Main

Medizinische Hochschule Hannover (MHH) - site P41, Hanover

Soroka MC - site P23, Beersheba

Shamir Medical Center (Assaf Harofeh) - site P28, Be’er Ya‘aqov

Carmel - site P27, Haifa

Rambam MC - site P22, Haifa

Shaarei Tszedek Medical Center - site P29, Jerusalem

Galilee Medical Center - site P24, Nahariya

EMMS Holy Family Nazareth Hospital - site P26, Nazareth

Assuta Medical Center - site P31, Tel Aviv

Tel-Aviv Sourasky Medical Center - site P30, Tel Aviv

University Hospitals Birmingham NHS Foundation Trust - site P05, Birmingham

Cambridge University Hospitals NHS Foundation Trust - Addenbrookes Hospital - site P09, Cambridge

NHS Greater Glasgow and Clyde - site P03, Glasgow

King's College Hospital NHS Foundation Trust - site P04, London

The Royal Free Hospital - site P01, London

Oxford University Hospitals NHS Foundation Trust- site P11, Oxford

Plymouth Hospitals NHS Trust - Derriford Hospital - site P07, Plymouth

LS9 7TF

Leeds Teaching Hospitals NHS Trust - site P08, Leeds

All Listed Sponsors
lead

ChemomAb Ltd.

INDUSTRY